Kalytera Initiates Program to Develop a Novel Cannabinoid -Based Compound for Treatment of …

Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the “Company” or “Kalytera”) today announced that it has begun development of a novel cannabinoid -based compound for the treatment of acute and chronic pain. Patents for this compound have been filed in the U.S. and other … Read More

The post Kalytera Initiates Program to Develop a Novel Cannabinoid -Based Compound for Treatment of … appeared first on Dagga Magazine.

…read more

Leave a Reply

Your email address will not be published. Required fields are marked *